Preclinical studies have suggested that metformin could inhibit the growth of BC cells via indirect and direct pathways by reducing the level of blood glucose and insulin, which involves AMPK-dependent and -independent mechanisms49,50. The gene discussed is INS; the disease is breast cancer.